National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 8) (No. PB 99 of 2012) (Cth)
PB 99 of 2012
National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 8)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 27 November 2012
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 8).
(2) This Determination may also be cited as PB 99 of 2012.
Commencement
This Determination commences on 1 December 2012.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Adrenaline
Insert
Aflibercept
[2] Schedule 1, after item dealing with Human Menopausal Gonadotrophin
Insert
Hyaluronic acid
[3] Schedule 1, after item dealing with Imatinib
Omit
Imiquimod
[4] Schedule 1, after item dealing with Nedocromil
Omit
Nevirapine
[5] Schedule 1, after item dealing with Rilpivirine
Omit
Riluzole
[6] Schedule 2, after item dealing with Amlodipine with Atorvastatin
Insert
Amlodipine with valsartan
Amlodipine with valsartan and hydrochlorothiazide
[7] Schedule 2, after item dealing with Imipramine
Insert
Imiquimod
[8] Schedule 2, after item dealing with Naproxen
Insert
Nevirapine
[9] Schedule 2, after item dealing with Ranitidine
Insert
Riluzole
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0